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Hearing loss (HL) is one of the most common sensory defects affecting more than 466 million 
individuals worldwide. It is clinically and genetically heterogeneous with over 120 genes causing 
non-syndromic HL identified to date. Here, we performed exome sequencing (ES) on a cohort of 
Iranian families with no disease-causing variants in known deafness-associated genes after 
screening with a targeted gene panel. We identified likely causal variants in 20 out of 71 families 
screened. Fifteen families segregated variants in known deafness-associated genes. Eight families 
segregated variants in novel candidate genes for HL: DBH, TOP3A, COX18, USP31, TCF19, 
SCP2, TENM1, and CARMIL1. In the three of these families, intrafamilial locus heterogeneity 
was observed with variants in both known and novel candidate genes. In aggregate, we were able 
to identify the underlying genetic cause of HL in nearly 30% of our study cohort using ES. This 
study corroborates the observation that high-throughput DNA sequencing in populations with high 
rates of consanguineous marriages represents a more appropriate strategy to elucidate the genetic 
etiology of heterogeneous conditions such as HL.
Introduction
Hearing, the process of translating physical sound waves into electrochemical signals is a 
highly dynamic and orchestrated process. The involvement of ~1% of the genes in the 
human genome makes hearing loss (HL) one of the most genetically heterogeneous 
conditions. Not surprisingly, this genetic heterogeneity is reflected at the phenotypic level 
with variability in type, onset, progression, symmetry, audioprofile, and severity.1
HL affects millions of people globally and could be due to genetic defects, environment, or 
both factors.2 Congenital sensorineural HL affects 1 in every 500 newborns in developed 
countries and it is estimated that ~50% of individuals will experience HL in their lifetimes 
due to damage induced by noise or aging. The rate of congenital HL, like many genetic 
diseases, increases in populations with high rate of consanguineous marriages, such as Iran.3 
These populations have played an important role in the identification of novel genes, 
specifically those associated with autosomal recessive hearing loss (ARHL).
Traditional approaches to novel gene identification took years and required families large 
enough to perform linkage analysis. Through the years, this approach has led to the 
identification of more than 75% of genes known to be implicated in HL. However, many 
families that were too small to establish a significant log of the odds (LOD) score or families 
with intrafamilial locus heterogeneity remained unsolved.4
Advances in genomic high-throughput sequencing offered new opportunities in genetic 
studies, including discovering causative genes in Mendelian diseases regardless of family 
size.5 Furthermore, they facilitated large-scale screening projects revealing an unprecedented 
genomic and variation diversity within the deafness-associated genes, and within distant 
ethnic groups.6, 7 It has now become feasible to investigate complex families, small families, 
and sporadic cases.
Using both single-gene sequencing and high-throughput sequencing, we previously revealed 
that GJB2 pathogenic variants are responsible for about 16% of autosomal-recessive non-
syndromic HL (ARNSHL) in the Iranian population.8 In a study of over 300 GJB2-negative 
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Iranian families, we identified the causative pathogenic variants in 67% of families using a 
custom Targeted Genomic Enrichment panel (OtoSCOPE V5&V6).9 Since these studies, 
significant advances in identifying genetic causes of HL in the Iranian population has been 
made as ~80% of the studied families were offered a positive genetic diagnosis for their HL 
using the above-mentioned methods.
In recent years, there has been a shift away from targeted gene panels to exome and genome 
sequencing. Their advantage lies in their ability to facilitate the discovery of novel genes 
underlying Mendelian diseases in individuals where known disease-causing genes have 
already been ruled out. This approach has been shown to be fruitful in diseases that are both 
genetically and phenotypically heterogeneous such as recessive cognitive disorders.
Here, we used a similar approach utilized by Najmabadi et al,10 to investigate the genetic 
causes of HL in 71 families. We identified pathogenic variants in known genes associated 
with HL, revealed an unexpected amount of intrafamilial locus heterogeneity, and identified 
eight novel candidate genes for HL. Overall, this study illustrates the power of using exome 
sequencing (ES) to unravel the genetics of HL and improves our understanding of the 
biology of hearing and deafness.
Materials and Methods
Patients included in this study were sequentially referred to the Genetics Research Center 
(GRC) at the University of Social Welfare and Rehabilitation Sciences (USWR) during the 
past 20 years for genetic testing. Prior to the start of the study, ethical approval was obtained 
from the Ethical Board of USWR. Each participant signed consent forms for their 
participation in this study. This study was conducted according to the ethical standards as 
defined by the Helsinki Declaration.
A detailed clinical examination was completed. Hearing thresholds were measured by pure-
tone audiometry at 250, 500, 1000, 2000, 4000, and 8000 Hz following standard protocols.
Prior to this study, all patients underwent genetic screening for pathogenic variants in GJB2 
using Sanger sequencing. Patients negative for variants in GJB2 were screened using 
OtoSCOPE panel (V5 & V6); a targeted gene panel covering deafness-associated genes as 
previously described.9 Considering that OtoSCOPE-negative families are a valuable cohort 
to identify novel deafness-associated genes, we studied 70 OtoSCOPE-negative families by 
ES. We also performed ES on one additional family without any prior screening with 
OtoSCOPE (Figure 1). In each family, only one affected member underwent ES, except 
three families (L-665, L-1119, and L-8600574). This study was conducted between 2015 
and 2019.
Exome enrichment was performed using Agilent SureSelectXT Human All Exon V6. All 
enriched libraries were sequenced on the Illumina NextSeq500 using 100 bp paired-end 
reads. After quality control assessment using the FastQC toolkit, 100–150 bp reads were 
aligned to the human reference genome hg19 using the Burrows-Wheeler Aligner (BWA).11 
Picard tool applied to perform BAM processing and then realignment of indel regions, 
recalibration of base qualities, and variant detection and calling were performed using the 
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Genome Analysis Toolkit (GATK)12 to produce variant call format files, which were then 
annotated using ANNOVAR.13 Variant filtering was based on quality/coverage depth (≥3) 
and minor allele frequency (MAF <0.5%) as reported in the Genome Aggregation Database 
(gnomAD) (https://gnomad.broadinstitute.org/).14 We also considered MAF of all these 
variants in the Iranome Database (http://www.iranome.com/).15 Variants meeting these 
criteria were further filtered based on inheritance mode, coding effect, and annotation for 
conservation and pathogenicity. All potentially causal variants detected by ES were validated 
by Sanger sequencing and co-segregation studies were performed, including all available 
and informative family members.
We prioritized candidate genes obtained through ES based on their expression pattern in the 
auditory system using the gEAR16 (https://umgear.org/) and SHIELD (https://
shield.hms.harvard.edu/).
The analysis of run of homozygosity (ROH) was performed with the Varbank v.3.4 exome 
pipeline of the Cologne Centre for Genomics (CCG), including alignment against the human 
GRCh38 reference genome using BWA-mem11 and variant calling with the GATK 
haplotype caller.12 Varbank uses a linkage-based approach with a recessive consanguineous 
inheritance model (https://varbank.ccg.uni-koeln.de/varbank2/). We constructed a pedigree 
with a first cousins’ relationship and assumed a disease allele frequency of 0.0001. Known 
high-quality single-nucleotide variants (SNVs) (GQ > 98; VQSLOD>2; QD > 6; MQ > 60; 
FS < 20; MQRankSum> − 2.5) with a maximum population allele frequency less than 80% 
according to gnomAD v2.0114 were chosen and run with Allegro v1.2c17 in overlapping 
windows of 2000 SNVs each. Regions with a LOD-score < 0.8 (maxLOD = 1.2) were 
filtered out. ROHs were considered for families exhibiting consanguinity.
Variants in known deafness-associated genes were checked in the Deafness Variation 
Database (https://deafnessvariationdatabase.org/) and classified according to the deafness-
specific ACMG/AMP guidelines and our expert curation.7, 18
The impact of amino acid substitutions and 3D modeling of wild-type and mutant amino 
acid in novel candidate genes were investigated using the Project Hope server, I-Tasser,19 
and PyMOL. Thermodynamic predictions were calculated using STRUM.20
Results
This study was conducted from 2015 to 2019 and some results have already been reported.
21, 22 In 20 out of 71 families investigated (~ 30%), plausible causal defects were identified 
in known deafness-associated genes as well as novel candidate genes, all co-segregating 
with HL. The phenotypic data of families are summarized in Table 1.
We identified 15 families with variations in known deafness-associated genes. Three 
families segregated pathogenic variants in CDC14A which are as follows: L-692 and 
L-1096: NM_003672.4:c.1126C > T:p.(Arg376*) and L-1347: 
NM_003672.4:c.1351_1352del: p.(Ala451Thrfs*43).21 Two families (L-350 and 
L-8900107) segregated the same pathogenic variant in NARS2 (NM_001243251.1: c.658A 
> G: p.[Met220Val]). Families L-1119 and L-8700223 segregated pathogenic variants in 
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TMIE, NM_147196.2:c.250C > T:p.(Arg84Trp) and c.122_125dup:p.(Pro43Alafs*73), 
respectively. In family L-665 a frameshift variant (NM_017433.5:c.1370_1371del:p.
[Arg457Asnfs*25]) in MYO3A was identified. Affected individuals in family L-1108 were 
homozygous for the previously described pathogenic variant (NM_001302455.2:c. 293C > 
T:p.[Thr98Met]) in EDN3. A novel pathogenic frameshift variant 
(NM_078485.4:c.1915del:p.[Val639Trpfs*51]) in COL9A1 was found co-segregating with 
Stickler syndrome (MIM:614134) in family L-1326. Pathogenic or likely pathogenic 
variants in CLDN14 (NM_012130.4:c.40_41insTGGTGCACGGCCGTGCA:p.
[Ser14Metfs*15]), ATP6V0A4 (NM_130840.3:c.710_712del:p.[Lys237del]), CLCNKA 
(NM_001042704.2:c.55C > T:p.[Gln19*]), MYO7A (NM_000260.4:c.5442 T > G: p.
[Tyr1814*]) and SLC52A2 (NM_001253815.2:c.973 T > G:p.[Cys325Gly]) were found to 
be co-segregating with deafness in families L-3100, L-8600034, L-8600220, L-8600574, 
and L-9501254 respectively (Figure 2). Audiograms for these families are shown in 
Supplementary Figure 1.
In summary, we identified 13 likely pathogenic or pathogenic deafness-causing variants in 
11 genes previously associated with non-syndromic or syndromic HL in our cohort. These 
variants comprise homozygous missense (n = 4), nonsense (n = 3), frameshift (n = 5), and 
in-frame deletion variants (n = 1). Five out of the 13 variants are novel and have not been 
previously linked to deafness (Table 2). In seven families, the causative genes are linked to 
syndromic forms of HL (EDN3, COL9A1, ATP6V0A4, CLCNKA, NARS2, MYO7A, and 
SLC52A2) (Table 1).
Family L-347 is a consanguineous family with Azeri ethnicity and profound ARNSHL 
(Figure 3A). We identified a missense variant (NM_000787.4:c.1486C > T:p.[Pro496Ser]) in 
DBH gene located in a ROH spanning 8 Mb. The p.(Pro496Ser) variant is highly conserved, 
predicted to be deleterious by in silico tools, and is absent from all population databases 
(Table 3).
Family L-665 with Fars ethnicity consists of multiple affected branches. Initially, DNA from 
individual V:5 was sent for ES, which revealed a homozygous frameshift variant in MYO3A 
(NM_017433.5:c.1370_1371del:p.[Arg457Asnfs*25]). This variant segregated with HL in 
generation V, but not in deaf individuals in generation VII (Figure 3(B)). The audioprofiles 
were different between the two branches (Table 1, Figure 3(B)). Subsequently, individual 
VII.1 was sent for ES. After variant filtering and prioritization, a missense variant 
(NM_004618.5:c.1651G > A; p.Val551Met) in TOP3A gene was identified. This novel 
variant alters a highly conserved residue, and it is predicted deleterious by in silico tools 
(Table 3).
Family L-1119 with Azeri ethnicity segregates HL in two branches (Figure 3(C)). Initially, 
we screened affected individual VI:4. After variant filtering, we identified an ultra-rare 
homozygous missense variant (NM_001300729.1:c.914G > A; p.[Arg305His]) in the 
COX18. This variant is located in a region of homozygosity of ~40 Mb. It is conserved and 
predicted to be damaging by in silico tools. This variant also segregated in a homozygous 
state in the affected sibling but not in the second branch of the family (Figure 3(C)). We then 
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performed ES on affected individual V:3 and identified the recurrent mutation 
(NM_147196.2:c.250C > T; p.Arg84Trp) in TMIE.
Two patients from a consanguineous family with Azeri ethnicity exhibited post-lingual 
moderate-to-severe NSHL (L-1208; Figure 3(D)). We identified a missense variant 
(NM_020718.3:c.2533A > G; p.[Ser845Gly]) in USP31 gene. This variant, located in a ~ 35 
Mb ROH, is ultra-rare (MAF < 0.0088% in gnomAD), impacts a highly conserved residue 
and is predicted damaging.
L-3033 is a non-consanguineous family of Fars ethnicity with three affected individuals (a 
mother and her two sons) with severe HL (Figure 3(E)). After exploring all inheritance 
modes; we identified a heterozygote missense variation (NM_001077511.2:c.482G > A; p.
[Arg161Gln]) in the TCF19 gene that segregated in this family. This variant is conserved and 
predicted to be deleterious by some in silico tools. It is rare (gnomAD MAF: 0.0011%) and 
absent from the Iranome database (Table 3).
In four affected individuals from a consanguineous marriage with Gilaki ethnicity and 
profound ARNSHL (L-8600456; Figure 3(F)), we identified a missense variant (c. 554A > 
G;p.[Asp185Gly]) in the SCP2 gene. The variant is ultra-rare, highly conserved, and located 
in 17 Mb ROH.
In L-8600574 family, three out of the five affected individuals had retinitis pigmentosa (RP) 
and deafness whereas the other two exhibited non-syndromic deafness only (Figure 3(G)). 
ES performed on one affected individual with deafness and RP, identified a truncating 
pathogenic variant (c.5442 T > G; p.Tyr1814*) in MYO7A. However, this variant did not 
segregate in the two affected individuals with isolated deafness. Subsequent ES of an 
individual with isolated deafness identified a deleterious and conserved variant (c.3273G > 
T; p.Gln1091His) in TENM1. This variant co-segregated with the non-syndromic HL. Since 
these two affected siblings were male, TENM1 gene represents a good novel X-linked 
candidate gene.
Family L-8900097 is of Azeri ethnicity with three affected individuals and profound 
deafness (Figure 3(H)). We identified a missense variant (NM_001173977.2:c.3245G > A;p.
[Arg1082Gln]) in the CARMIL1 gene that segregated with deafness. This variant is located 
inside a ROH of ~15 Mb. It is rare (MAF: 0.004416% in gnomAD), highly conserved, and 
predicted to be damaging.
Discussion
HL is the most common congenital sensory impairment, affecting around 466 million people 
worldwide. The HHL homepage currently lists more than 120 genes for NSHL; and it is 
estimated that HL is part of more than 400 genetic syndromes. The multitude of genes and 
variants and different inheritance patterns involved in HL pathogenesis along with the 
clinical heterogeneity, make the establishment of proper diagnosis difficult.7
This study involved 71 multiplex families from Iran. Using ES, we identified plausible 
causal genetic defects in 20 families (~30%). Pathogenic and likely pathogenic variants were 
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identified in 11 known deafness-associated genes. Five out of the 13 (38.4%) identified 
variants in known genes are novel and not yet linked to deafness. Variants in eight novel 
candidate genes were also identified (Tables 2 and 3).
In two families, pathogenic variants in COL9A1 and ATP6V0A4 made it possible to 
diagnose two families with syndromic HL; Stickler syndrome type IV and distal renal 
tubular acidosis (dRTA) 3, respectively. We identified a missense variant in SLC52A2 gene 
in a consanguineous family with Brown Vialetta van Laere syndrome. Early diagnosis of this 
syndrome may be lifesaving as high-dose oral riboflavin therapy has been reported to result 
in clinical improvement.23 Pathogenic variants in EDN3 associated with Waardenburg 
syndrome type 4B and CLCNKA associated with Bartter Syndrome, Type 4B were found 
each in one family.
Variants in NARS2 are involved in both syndromic (Combined oxidative phosphorylation 
deficiency 24 MIM: 616239) and NSHL (Deafness, autosomal recessive 94 MIM:618434). 
Families L-350 and L-8900107 with the same mutation in NARS2 are not from the same 
village or geographical location or ethnicity. Affected individuals in family L-8900107 
underwent clinical reevaluation and showed syndromic form of NARS2. We could not 
collect more detailed clinical data for family L-350, so it is unclear whether this family has 
syndromic HL or NSHL.
In three families, intrafamilial locus heterogeneity was detected. Family L-8600574 
presented both syndromic and NSHL within the core family. In L-665 and L-1119, two 
different genes have been identified in different branches. These cases highlight the 
importance of comprehensive clinical and molecular characterization of patients within the 
same pedigree to recognize possible distinct phenotypes and underlying genetic defects. 
This is valuable in establishing a correct diagnosis and thereby providing appropriate genetic 
counseling.
The c.1486C > T variant in the DBH gene changes a highly conserved proline into serine at 
position 496. The wild-type residue and newly introduced mutant residue differ in size, 
charge, and hydrophobicity. Prolines are very rigid conferring a special backbone 
conformation; the alteration to serine is predicted to disturb this conformation (Figure 4(A)). 
This is supported by a large change in free energy folding between the wide-type and mutant 
residues (ΔΔG:−1.65). The Dopamine beta-hydroxylase protein is predicted to interact with 
the LRTOMT protein, which is responsible for DFNB63-related deafness. The DBH is a 
biosynthetic enzyme catalyzing the formation of norepinephrine (NE) in the noradrenergic 
nerve endings of the central and peripheral nervous systems. In 2010, Maison et al. found 
that the Dbh−/− mice are significantly more vulnerable to middle-ear infection than 
littermate controls.24 Shepard et al. suggested that the NE is required for critical period 
plasticity in the auditory cortex, while intrinsic tonotopic patterning of auditory cortical 
circuitry occurs independently from NE. In 2018, Lee et al. reported that the catecholamine 
NE acts in the auditory cortex to shape local processing of complex sound stimuli. 
Moreover, it also enhances the coding accuracy of neurons in the auditory cortex as well as 
the downstream sensorimotor cortex.25
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Topoisomerase 3a is required for segregation of human mtDNA. Pathogenic variants in 
TOP3A have been linked to two different conditions: progressive external ophthalmoplegia 
with mitochondrial DNA deletions, autosomal recessive 5 (MIM: 618098), and 
microcephaly, growth restriction, and increased sister chromatid exchange 2 (MIM: 618097). 
The two affected individuals in L-665 family (branch 2) presented post-lingual NSHL with 
no other symptoms. The variant c.1651G > A:p.(Val551Met) in TOP3A gene changes a 
highly conserved residue and occurs in the active domain of TOP3A that may disturb contact 
with other molecules and might affect the signal transduction between the domains (Figure 
4(B)). This gene is highly expressed in the inner ear in mice. The three identified DNA 
topoisomerases in mammalian mitochondria (I, IIβ, IIIα) could solve any topological 
problems in replication, transcription, and cellular transactions.26–28 Wenjun Xia et al. 
recently identified pathogenic variants in TOP2B gene as a cause of ADHL in a Chinese 
family with 48 members. Affected individuals showed progressive mild post-lingual HL. 
They found significant abnormalities in the inner ear in top2b knockdown zebrafish. Their 
work showed that top2b has a critical role in the PI3K-Akt pathway and its alteration will 
reduce the number of supporting cells and hair cells.29
The c.914G > A variant in the COX18 gene changes arginine into histidine at position 305. 
Molecular modeling showed that Arg305 interacts with three other amino acids: Pro302, 
Gln306, and Phe328. Changing residue 305 to His disturbs interactions with Gln306 and 
Phe328 (Figure 4(C)). This variant is in the repeated domain named mitochondrial matrix 
and is predicted to disturb its function. The COX18 protein is required for the insertion of 
integral membrane proteins into mitochondrial inner membrane. It is essential for the 
activity and assembly of cytochrome c oxidase and plays a central role in the translocation 
and export of the C-terminal part of the COX2 protein into the mitochondrial intermembrane 
space. A previous study in mice showed an association between the Cox2 gene and 
sensorineural HL. There is an interaction between COX18 and COX2 for promoting 
translocation in the inner membrane.30
USP31 is an ubiquitin-related gene that recognizes and hydrolyzes the peptide bond at the 
C-terminal of ubiquitin and is involved in the processing of poly-ubiquitin precursors. In 
Border Collies, SNPs in USP31 were strongly associated with adult-onset deafness, possibly 
by a dysregulation of NF-kB activity; which is associated with increased levels of cochlear 
apoptosis and HL.31 The c.2533A > G variant in the USP31 gene identified in L-1208 
family changes serine into glycine at position 845. The mutant residue is smaller and more 
flexible than the wild-type residue, which might cause loss of interactions or disrupts protein 
conformation. 3D modeling showed alteration of the interaction of mutant residue with the 
other residues (Figure 4(D)). More recently, Kazmierczak et al. implicated another member 
of the ubiquitin protein family (USP53) as a novel component of tight junction-associated 
proteins in the cochlear epithelial cells that is essential for the survival of auditory hair cells 
and normal hearing in mice.32
The c.482G > A variant in TCF19 gene changes arginine into glutamine at position 161. The 
wild-type residue is positively charged whereas the mutant residue is neutral. 3D modeling 
showed this change results in the loss of one hydrogen bond (Figure 4(E)). The TCF19 
protein is a trans-activating factor that has a critical role in cell cycle progression.33 In one 
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study, it has been shown that SPARC and TCF19 have critical roles in the development and 
function of cochlea in the rat. The TCF19 gene is highly expressed in connective tissues of 
the cochlea.34 It has also been shown that TCF19 is regulated by vezatin, a protein 
associated with actin filaments and is essential for the sound plasticity of cochlear hair cells.
35 It is possible that the p.Arg161Glu perturbs or alters this interaction resulting in 
dysregulation of TCF19. More recently, while exploring the role of ATOH1 in vestibular 
hair cell regeneration, Taylor et al. showed adenoviral transduction of human vestibular 
epithelium with ATOH1 upregulated several important transcription factors, including 
TCF19. The addition of ATOH1 and the upregulation of these transcription factors 
supported the differentiation of supporting cells into hair cell-like cells.36
The c. 554A > G variant in the SCP2 gene changes aspartic acid into a glycine at position 
185. 3D modeling predicted that the wild-type residue interacts with Val25 and Ser81 but in 
the presence of Gly, the interaction with Ser81 is lost (Figure 4(F)). Furthermore, this 
variation impairs the thiolase_N domain, which is an important domain for the protein 
function. The SCP2 protein is a peroxisomal enzyme with thiolase activity that is required 
for the breakdown of branched-chain fatty acids. Variants in SCP2 have been linked to a 
spectrum of phenotypes linked to abnormal fatty-acid acyl-CoA metabolism and Zellweger 
syndrome.37, 38 A computational analysis of interacting partners of SCP2 revealed 
interaction with other members of the peroxisomal pathway including ACOX1, PEX5, 
PEX14, and HSD17B4.39, 40 The latter is a known gene associated with syndromic deafness. 
It is worth noting that the affected individuals in family L-8600456 do not present any of the 
previously reported symptoms associated with SCP2 protein defect.
The c.3273G > T variant in the TENM1 gene changes glutamine into histidine at position 
1091. In 3D modeling, His1091, loses interaction with Tyr1089, and interacts with Lys1092 
as compared to the wild-type residue (Figure 4(G)). The wild-type amino acid is highly 
conserved, and its alteration is predicted to be deleterious. The TENM1 protein belongs to 
the teneurins family genes, such as cell adhesion molecules and plays a role in regulating the 
establishment of proper connectivity within the nervous system. In mice, TENM1 is 
expressed in the embryonic nervous system, sensory organs, and widely in the auditory 
system. In Drosophila melanogaster, this protein has a synaptic-partner-matching role 
between axons in the olfactory sensory neurons and target neurons. It also has a critical role 
in synapse organization in the olfactory system.41 In chick, expression of teneurin-1 is 
detected in different brain regions involved in various processes including the processing of 
auditory information, general sensation, olfaction, and the coordination of complex motor 
behavior.42
The c. 3245G > A variant in the CARMIL1 gene changes arginine into glutamine at residue 
1082. The wild-type arginine has a positive charge, unlike the mutant glutamine that has no 
charged side chain. The wild-type arginine interacts with residues Ser1080 and Glu1081, but 
with the mutant residue, the interaction with Glu1081 is lost (Figure 4(H)). The CARMIL1 
gene encodes a F-actin uncapping protein comprised of 11 leucine-rich repeats, a coil–coil 
domain and a CAPZA2 inhibitory region. The p.Arg1082Glu variant is located in the 
CAPZA2 inhibitory region and could perturb this interaction, which may result in 
dysregulation of F-actin capping. The CARMIL1 multidomain protein has critical roles in 
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the cell such as cell development, differentiation, and disease. CARMIL1 regulates actin 
assembly, which is important to actin motility. For actin motility, CARMIL1 has interaction 
with Myosin 1E, Myosin 1C, and Twinfilin.43 Pathogenic variants in myosin proteins have 
been linked to hearing problems, because of the contributions of this protein to intracellular 
functions such as transportation, actin-binding, and signaling. Studies showed that Twinfilin 
and CARMIL interaction regulates actin assembly in mechanosensory stereocilia in the 
inner ear.44
We identified 13 pathogenic variants in known genes. Missed diagnoses using a targeted 
gene panel were due to several reasons. In one case, the indel variant in CLDN14 gene was 
identified but the genotype was inaccurate (heterozygote instead of homozygote) due to 
mapping error for indels in early versions of the analytical pipeline. In nine families, the 
identified causal genes were not covered on early versions of OtoSCOPE (V5 & V6) and 
thus were not screened. In two cases (L-665 and L-1119), intrafamilial genetic heterogeneity 
prevented the identification of the second cause of HL in the other branches of the family for 
which affected individuals were not screened with OtoSCOPE. Although the diagnosis for 
these families was initially missed; given evolving panel designs coupled with the high 
throughput, accuracy in variant calling and the ability to do high-resolution CNV calling, a 
tiered approach such as described here is still the most practical approach to diagnostics and 
novel gene discovery.
We identified eight potential novel candidate genes in Iranian patients (DBH, TOP3A, 
COX18, USP31, TCF19, SCP2, TENM1, and CARMIL1). We cannot conclusively assert 
their implication in HL due to the lack of additional families and functional studies. 
However, we believe publishing these findings and sharing them with the larger auditory 
community will give others the chance to look for them in their cohorts and potentially 
further validate them. Functional studies are required to confirm and evaluate the role of 
these genes in deafness.
For some families, our genetic study did not identify any genetic cause. Several reasons 
could explain these findings: aetiologic heterogeneity within families; poor ES depth of 
coverage in some regions; causative variant located in intronic or intergenic regions, and 
missed CNVs using ES data. Investigating these families using genome sequencing may 
resolve some of these challenges.
In conclusion, using technologies such as ES in genetically and clinically heterogeneous 
disorders and in populations with a high rate of consanguinity greatly accelerates the 
identification of the many novel genes that are hitherto unknown. The discovery of novel 
genes responsible for HL improves our knowledge of the mechanisms and pathways 
involved in this condition. It also creates opportunities for carrier screening among relatives 
and offer opportunities for informed choice in family planning, thus providing a direct 
benefit to families, communities, and to public health.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Flow diagram demonstrates the process of identifying the genetic cause of hereditary 
hearing loss in affected families in this study
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Pedigrees and genotypes of families with variants in known genes (*individuals run on 
OtoSCOPE, **individuals run on ES). ES, exome sequencing
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Pedigrees, genotypes and audiograms of families with novel candidate genes (*individuals 
run on OtoSCOPE, **individuals run on ES). ES, exome sequencing
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3D modeling of wild-type and mutant residue in protein structure of novel candidate genes.
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